Patients with obesity and T2D exhibited decreased (P < 0.05) jejunum gene expression levels of NLRP6 and its main effector IL18 together with increased (P < 0.05) mRNA levels of inflammatory markers. The gene discussed is NLRP6; the disease is obesity due to melanocortin 4 receptor deficiency.